This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Working towards the next breakthrough in Haemophilia
– Meet the people behind our treatment pipeline
Stine works in haemophilia research at Novo Nordisk

In the film below, Senior scientist in haemophilia, Stine Louise Reedtz-Runge, talks about the company's search for novel solutions in haemophilia treatment and how the hope of finding new treatments that can help boys live more normally with this condition keeps her motivated.

Light at the end of the tunnel

Haemophillia research at Novo Nordisk
We continually explore new ways to address the unmet needs of people with haemophilia through the broadest portfolio of haemophilia research and development in the industry.
Our strong pipeline is driven by a determination to improve treatment options, and we are working on compounds that treat bleeds fast and effectively and therapies that offer convenience.

Other portraits in this series
| Protein discovery | diabetes research | Inflammation research | Device innovation |










